Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

HCWB
HCW Biologics Inc. Common Stock
stock NASDAQ

At Close
Jun 24, 2026 3:58:04 PM EDT
1.10USD+1.389%(+0.02)187,296
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jun 24, 2026 9:28:30 AM EDT
1.05USD-2.778%(-0.03)2,311
After-hours
Jun 24, 2026 4:57:30 PM EDT
1.11USD+1.242%(+0.01)8,222
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 24, 2022
07:00AM EST  Masonic Cancer Center at the University of Minnesota Receives FDA   GlobeNewswire Inc
Jan 20, 2022
08:18AM EST  HCW Biologics Inc. Announces Its Lead Product Candidate Shown To Augment Anti-Tumor Activity And Reduce Side Effects Of Chemotherapy Regimens   Benzinga
08:00AM EST  HCW Biologics Inc. Announces its Lead Product Candidate Shown to   GlobeNewswire Inc
Jan 19, 2022
08:00AM EST  HCW Biologics Founder and CEO Dr. Hing C. Wong   GlobeNewswire Inc
Jan 6, 2022
07:33AM EST  HCW Biologics to Participate in H.C. Wainwright BioConnect   GlobeNewswire Inc
Dec 13, 2021
07:31AM EST  HCW Biologics Founder and CEO Dr. Hing C. Wong   GlobeNewswire Inc
Nov 19, 2021
10:09AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021   Benzinga
08:42AM EST  EF Hutton Initiates Coverage On HCW Biologics with Buy Rating, Announces Price Target of $10   Benzinga
Nov 12, 2021
07:00AM EST  HCW Biologics Reports Third Quarter Financial Results and Recent   GlobeNewswire Inc
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 29, 2021
06:14AM EDT  The following are some of the stocks making big moves in Friday's pre-market trading (as of 05.45 A.M. EDT).   RTTNews
Oct 28, 2021
02:45PM EDT  Mid-Afternoon Market Update: Dow Surges 160 Points; Wolfspeed Shares Gain After Q1 Results   Benzinga
12:16PM EDT  Mid-Day Market Update: Nasdaq Rises Over 1%; Rafael Holdings Shares Slide   Benzinga
12:13PM EDT  Why Did HCW Biologics Shares More Than Double Today?   Benzinga
10:44AM EDT  Mid-Morning Market Update: Markets Rise; Caterpillar Profit Beats Expectations   Benzinga
08:26AM EDT  The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug   Benzinga
07:29AM EDT  HCW Biologics Receives FDA Clearance To Proceed With Phase 1b Clinical Trial For Immunotherapeutic HCW9218 For Pancreatic Cancer   Benzinga
07:00AM EDT  Company cleared to proceed with first-in-human clinical trial to evaluate HCW9218, Companys lead product candidate, in refractory, advanced/metastatic pancreatic cancer   GlobeNewswire Inc
Oct 27, 2021
07:00AM EDT  HCW Biologics Announces Appointment of Two New Members to Board of   GlobeNewswire Inc
Oct 20, 2021
10:32AM EDT  Mid-Morning Market Update: Markets Open Higher; Verizon Posts Upbeat Earnings   Benzinga
Oct 19, 2021
02:35PM EDT  Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher   Benzinga
12:11PM EDT  Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge   Benzinga
Oct 7, 2021
08:24AM EDT  The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results   Benzinga
Oct 6, 2021
07:33AM EDT  The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal   Benzinga
Oct 5, 2021
08:01AM EDT  The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout   Benzinga
Sep 29, 2021
08:13AM EDT  The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug   Benzinga
Sep 21, 2021
08:20AM EDT  The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data   Benzinga
Aug 24, 2021
08:09AM EDT  The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal   Benzinga
07:47AM EDT  HCW Biologics Highlights Publication Of Paper In Molecular Therapy Titled 'Bifunctional TGF- trap/IL-15 Protein Complex Elicits Potent NK Cell and CD8+ T Cell Immunity Against Solid Tumors'   Benzinga
07:32AM EDT  Lead Drug Candidate Engineered Using Tissue FactOr-Based FusIon (TOBI) Platform   GlobeNewswire Inc
Aug 20, 2021
07:45AM EDT  The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data   Benzinga
Aug 17, 2021
07:33AM EDT  HCW Biologics Highlights Article Published In Cancer Immunology Research Validates Novel Tissue Factor Scaffold Fusion Protein Discovery Platform   Benzinga
07:32AM EDT  TOBIDiscovery Platform Creates GMP-Scale Heteromeric Fusion Protein Complexes (HFPCs) That Solve Issues with Multi-Signal Receptor Engagement on Immune Cells   GlobeNewswire Inc
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
07:10AM EDT  HCW Biologics Inc. (the Company) (NASDAQ: HCWB), an innovative, biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, today reported financial results and recent business highlights for its second quarter ended June 30, 2021.   GlobeNewswire Inc
07:08AM EDT  HCW Biologics Q2 Net Loss $2.8M, Same YoY   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Jul 28, 2021
10:14AM EDT  The IPO Recap Party Is Everything But Over   Benzinga
Jul 23, 2021
07:45AM EDT  The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs   Benzinga
Jul 22, 2021
04:05PM EDT  HCW Biologics Inc. Announces Closing of $56.0 Million Initial   GlobeNewswire Inc
11:34AM EDT  The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO   Benzinga
Jul 20, 2021
10:49AM EDT  HCW Biologics Shares Open For Trade At $7.78; IPO Priced At $8/Share   Benzinga
Jul 19, 2021
06:40PM EDT  HCW Biologics Inc. Announces Pricing of $56.0 Million Initial   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC